Septerna, Inc
Advertisement
Septerna, Inc, situated in South San Francisco, CA, is dedicated to pioneering a new era of GPCR drug discovery. The company focuses on unlocking the full potential of G protein-coupled receptor (GPCR) drug targets to develop impactful new medicines across therapeutic areas.
Powered by their proprietary Native Complex Platform™, Septerna is at the forefront of discovering innovative ways to drug GPCRs. Their industrial-scale platform is designed to unlock challenging GPCRs, leading to the development of a pipeline of oral small molecule drug candidates.
Septerna boasts a world-class team of drug hunters, GPCR experts, and drug developers committed to advancing cutting-edge science. Their collaboration-driven approach and relentless focus on developing novel oral small molecule GPCR-targeted programs set them apart in the industry.
Generated from the website content
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
